Great news from one of our newest members Kye Pharmaceuticals! https://lnkd.in/gUNvTG35
The first-and-only extended-release chewable methylphenidate tablets approved by Health Canada. QUILLIVANT® ER Chewable Tablets are now available in Canada! Great news for many young people across Canada, and a terrific milestone for the team at Kye Pharmaceuticals. #Kyeproud
Can we #manufacture more #drugs in Europe? The article in the Sueddeutsche Zeitung outlines some challenges around pharmaceutical manufacturing in Europe based on the Sandoz antibiotics plant in Kundl/Austria. Every second package of antibiotics sold in Europe had some relationship to this plant: 1️⃣ Yield in Kundl has been optimized over many years and it is not straightforward to just transfer this to new plants. 2️⃣ Annual energy consumption of the plant is similar to a city of the size of Innsbruck 3️⃣ A key ingredient is sugar with an annual demand of 50000 tons (prices partially tripled). 4️⃣ Margins seem unattractive for Norvatis that aims to spin-off Sandoz The ultimate question certainly is if health insurances and governments are willing to pay more for made-in-Europe given the tight budgets. Full article for subscription here: https://lnkd.in/eSJkZRh3 #drugs #supplychain
MBA Pharmaceutical Management,NIPER Hyderabad | Intern at TheraTraQ (Competitive Intelligence) | M.Pharm (Pharmaceutics) | B.Pharm
Big win for Alembic Pharmaceuticals Limited! 🎉 𝐓𝐡𝐞𝐲'𝐯𝐞 𝐫𝐞𝐜𝐞𝐢𝐯𝐞𝐝 𝐔𝐒𝐅𝐃𝐀 𝐚𝐩𝐩𝐫𝐨𝐯𝐚𝐥 𝐟𝐨𝐫 𝐠𝐞𝐧𝐞𝐫𝐢𝐜 𝐈𝐜𝐚𝐭𝐢𝐛𝐚𝐧𝐭 𝐢𝐧𝐣𝐞𝐜𝐭𝐢𝐨𝐧. ⏺𝐅𝐢𝐫𝐬𝐭 𝐨𝐟 𝐢𝐭𝐬 𝐤𝐢𝐧𝐝: This marks Alembic Pharma's first peptide product approved by the USFDA. ⏺𝐓𝐫𝐞𝐚𝐭𝐢𝐧𝐠 𝐡𝐞𝐫𝐞𝐝𝐢𝐭𝐚𝐫𝐲 𝐚𝐧𝐠𝐢𝐨𝐞𝐝𝐞𝐦𝐚 (𝐇𝐀𝐄): Icatibant injection helps adults manage acute HAE attacks, a condition causing severe swelling. ⏺𝐒𝐢𝐠𝐧𝐢𝐟𝐢𝐜𝐚𝐧𝐭 𝐦𝐚𝐫𝐤𝐞𝐭 𝐩𝐨𝐭𝐞𝐧𝐭𝐢𝐚𝐥: The Icatibant injection market is estimated at $112 million (IQVIA data). ⏺𝐁𝐫𝐨𝐚𝐝𝐞𝐧𝐬 𝐭𝐡𝐞𝐢𝐫 𝐨𝐟𝐟𝐞𝐫𝐢𝐧𝐠: This approval strengthens Alembic Pharma's position in the US market for critical care medications. #AlembicPharma #USFDA #HereditaryAngioedema #GenericDrugs #Healthcare
#Sedatives Market Growing Popularity and Emerging Trends 2022 to 2030 >> https://lnkd.in/gJbTQnt4 #Stressed working #conditions with drastically changing #lifestyles are the factors driving sedatives market #growth. Rising intake of #stimulating #beverages such as #coffee, #tea & #energy #drinks leading to insomnia is another factor fueling the #sedatives market. Advicenne, AstraZeneca, Concert Pharmaceuticals, Inc., Drawbridge Pharmaceuticals Pty Ltd., NanoMedex Pharmaceuticals, Inc., PAION AG, Takeda Pharmaceuticals. #sedatives #medical #pharmaceuticals #health #medicines #medicine #pharmaceuticalsciences
#Sedatives Market Growing Popularity and Emerging Trends 2022 to 2030 >> https://lnkd.in/gJbTQnt4 Sedative Sigorta SEDATIVE SECURITY & INVESTIGATION SERVICE PRIVATE LIMITED TRANQUILIZER & SEDATIVE #sedatives #medical #pharmaceuticals #health #medicines #medicine #pharmaceuticalsciences
#Sedatives Market Growing Popularity and Emerging Trends 2022 to 2030 >> https://lnkd.in/gJbTQnt4 #Stressed working #conditions with drastically changing #lifestyles are the factors driving sedatives market #growth. Rising intake of #stimulating #beverages such as #coffee, #tea & #energy #drinks leading to insomnia is another factor fueling the #sedatives market. Advicenne, AstraZeneca, Concert Pharmaceuticals, Inc., Drawbridge Pharmaceuticals Pty Ltd., NanoMedex Pharmaceuticals, Inc., PAION AG, Takeda Pharmaceuticals. #sedatives #medical #pharmaceuticals #health #medicines #medicine #pharmaceuticalsciences
💊✨ Acurx Pharmaceuticals, Inc. (Nasdaq: ACXP). believes Ibezapolstat could reach a market exceeding $1 billion in value. What are your thoughts on this potential breakthrough? Share below! ⬇️ 1 Watch the full interview here⬇️⬇️⬇️ https://lnkd.in/epQrKZMQ #acurxpharmaceuticals #wellness #business #newtothestreet #health #healthcare #cure #medicine #pharmacy #science
Biosimilars contribute to the sustainability of the healthcare system via: ✔️ Reduced cost ✔️ Increased competition ✔️ Improved drug accessibility When it comes to biosimilars, you can trust in Teva Canada as a key partner. Before any biosimilar is approved by Health Canada, they go through an extremely thorough authorization process based on how similar they are to their reference biologic drug. Teva Canada is committed to ensuring our biosimilars are manufactured in state-of-the-art facilities with the highest-quality agents. Take a look at the robust Biosimilar Regulatory pathway https://ow.ly/seYY50Q5Gqt Discover more on biosimilars by following #GlobalBiosimilarsWeek https://ow.ly/PivB50Q5Gqu #TevaCanada #GBW2023 #biosimilars #CommittedToCanadians
Access to quality medicines is a fundamental human right. At Ecumenical Pharmaceutical Network, Richard Neci reflects on the need for solutions to combat health inequity in Africa. At the Access to Medicine Foundation, our main mission is to influence pharmaceutical companies to expand access of their healthcare products, especially in low- to middle-income countries. This includes engaging with these companies and embracing approaches of affordability, quality and availability. In this video, learn more about the tangible ways organisations like Ecumenical Pharmaceutical Network use our findings to advance access. #LCIM #AccesstoMedicine #GlobalHealth #pharma
At our recent Amsterdam Session on #diabetes care, we had the opportunity to sit down for an interview with Richard Neci, Executive Director of the Ecumenical Pharmaceutical Network. He offered insights into how the #AccesstoMedicine Foundation is catalysing change by mobilising essential #healthcare companies and discussed his approach to integrating the Foundation’s research into his own work. Richard emphasises the importance of the Foundation’s Amsterdam Sessions for #DiabetesCare. He highlights that these sessions serve as a platform for participants and organisations to discuss and address the challenges surrounding the affordability and availability of essential diabetes products. You can watch the full interview here 👉 https://lnkd.in/eTgKfBTb #EquitableAccess #AccesstoHealthcare #HealthcareEquity #GlobalHealth #changemaking #impact
